Covid-19: What now for remdesivir?
This opinion-based article discusses the role of remdesivir as a treatment for covid-19 in the context of a WHO trial which found evidence of little clinical benefit and draws parallels to oseltamivir (Tamiflu) which was stockpiled in anticipation of flu pandemics.
Source:
British Medical Journal
SPS commentary:
WHO remdesivir recommendation